MIP
RMD icon

Marietta Investment Partners’s ResMed RMD Stock Holding History

Marietta Investment Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,060
Closed -$238K – 176
2026
Q1 		$238K Sell
1,060
-150
-12% -$37.4K 0.05% 151
2025
Q4 		$291K Sell
1,210
-8,648
-88% -$2.21M 0.06% 146
2025
Q3 		$2.7M Buy
+9,858
New +$2.69M 0.52% 53

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Marietta Investment Partners's RMD Position: Q2 2026 in Review

Marietta Investment Partners sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,060 shares — an estimated $238K sold.

Marietta Investment Partners first reported a position in RMD in Q3 2025 and held it in 3 quarters. The position peaked at $2.7M in Q3 2025. 762 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Marietta Investment Partners reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Marietta Investment Partners sold 1,060 ResMed shares in Q2 2026, an estimated $238K.
  • Marietta Investment Partners first reported a position in ResMed in Q3 2025 and held it in 3 quarters.
  • Marietta Investment Partners's ResMed position peaked at $2.7M in Q3 2025.
  • 762 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Marietta Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.